ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Sclerosis (MS) in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Sclerosis
Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Chronic Progressive Multiple Sclerosis
Amyotrophic Lateral Sclerosis
Motor Neuron Disease
Muscle Spasticity

Multiple Sclerosis (MS) trials near Austin, TX, USA:

A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis (OLIKOS)

A single arm study evaluating the continued efficacy, safety and tolerability of ofatumumab in patients with relapsing multiple sclerosis...

Active, not recruiting
Relapsing Multiple Sclerosis
Drug: Ofatumumab

Phase 3

Novartis
Novartis

Round Rock, Texas, United States and 20 other locations

for the overall conduct of the study at the site, confirmation of subject eligibility, routine study subject clinical management including for MS...

Active, not recruiting
Multiple Sclerosis
Drug: RPC-1063

Phase 3

Celgene
Celgene

Round Rock, Texas, United States and 60 other locations

The purpose of this study is to evaluate long-term safety and efficacy of ublituximab therapy in participants with relapsing multiple sclerosis...

Active, not recruiting
Relapsing Multiple Sclerosis (RMS)
Biological: Ublituximab

Phase 3

TG Therapeutics
TG Therapeutics

Round Rock, Texas, United States and 85 other locations

This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sc...

Active, not recruiting
Progressive Multiple Sclerosis (PMS)
Drug: Ocrelizumab

Phase 3

Roche
Roche

Round Rock, Texas, United States and 125 other locations

) neo-antigen in subjects with relapsing multiple sclerosis (RMS)....

Enrolling
Relapsing Multiple Sclerosis
Biological: 23-valent pneumococcal polysaccharide vaccine (23-PPV)
Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)

Phase 3

Novartis
Novartis

Round Rock, Texas, United States and 301 other locations

This is a Phase IIIb, single-arm, multicenter, OLE study. Participants receiving ocrelizumab as an investigational medicinal product (IMP) in a Roche...

Active, not recruiting
Multiple Sclerosis
Drug: Ocrelizumab

Phase 3

Roche
Roche

Round Rock, Texas, United States and 239 other locations

The objective of this study is to assess the long-term safety, tolerability, and efficacy of adjunctive therapy of LP352 in subjects with development...

Active, not recruiting
Developmental and Epileptic Encephalopathy
Lennox-Gastaut Syndrome
Drug: LP352, bexicaserin

Phase 2

Longboard Pharmaceuticals

Austin, Texas, United States and 27 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems